Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer

Growing evidence suggests a clear role of the host immune system in HER2+ breast cancer. In addition, HER2+ breast cancer is generally considered more immunogenic than hormone receptor-positive (HR+)/HER2-, and specific molecular HER2+ subgroups (e.g. HER2-enriched disease) are more immunogenic than...

Descripción completa

Detalles Bibliográficos
Autores principales: Griguolo, Gaia, Pascual, Tomás, Dieci, Maria Vittoria, Guarneri, Valentina, Prat, Aleix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439986/
https://www.ncbi.nlm.nih.gov/pubmed/30922362
http://dx.doi.org/10.1186/s40425-019-0548-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439986/
https://www.ncbi.nlm.nih.gov/pubmed/30922362
http://dx.doi.org/10.1186/s40425-019-0548-6

Ejemplares similares